2025-11-23 - Analysis Report
Okay, here's a comprehensive analysis of Northrop Grumman (NOC) based on the data you provided.  The report is structured to first present the raw numbers, then a brief analysis.

## Northrop Grumman (NOC) Stock Analysis

**Company Overview:** Northrop Grumman Corp. is a global aerospace and defense technology company.

### 1. Performance vs. S&P 500 (VOO)

*   **NOC Cumulative Return:** 46.75%
*   **VOO (S&P 500) Cumulative Return:** 94.64%
*   **Absolute Divergence:** -55.3%
*   **Divergence Range:** Max 56.9%, Min -58.5%
*   **Relative Divergence:** 2.8%

**Analysis:** NOC has significantly underperformed the S&P 500 over the period examined. The Relative Divergence indicates that NOC's current performance is near the bottom of its historical divergence range compared to the S&P 500.

#### Alpha, Beta Analysis

| Year       | CAGR    | MDD     | Alpha  | Beta | Cap(B) |
|------------|---------|---------|--------|------|--------|
| 2015-2017  | 46.0%   | 65.6%   | 18.0%  | -0.1 | 43.9   |
| 2016-2018  | -2.0%   | 74.3%   | -17.0% | 0.0  | 35.1   |
| 2017-2019  | 17.0%   | 79.2%   | -5.0%  | 0.9  | 49.2   |
| 2018-2020  | -28.0%  | 79.9%   | -52.0% | 0.8  | 43.6   |
| 2019-2021  | 43.0%   | 79.9%   | -4.0%  | 0.8  | 55.4   |
| 2020-2022  | 18.0%   | 79.9%   | 19.0%  | 0.3  | 78.1   |
| 2021-2023  | 24.0%   | 82.7%   | 23.0%  | 0.2  | 67.0   |
| 2022-2024  | -15.0%  | 82.7%   | -36.0% | 0.2  | 67.2   |
| 2023-2025  | -4.0%   | 82.1%   | -63.0% | 0.1  | 81.1   |

**Analysis:**

*   **CAGR:** Fluctuates significantly, showing periods of high growth and contraction.
*   **MDD:** Very high Maximum Drawdown values suggest substantial risk and volatility.
*   **Alpha:** Generally negative, indicating underperformance relative to the benchmark, except for the 2015-2017 and 2020-2023 periods.  The recent negative alpha is concerning.
*   **Beta:** Generally low (close to zero), suggesting NOC's price is not strongly correlated to market movements.
*   **Cap(B):** Market capitalization has generally increased over time, indicating company growth.

### 2. Recent Price Action

*   **Current Price:** 566.70
*   **Previous Close:** 567.35
*   **Change:** -0.11
*   **5-day Moving Average:** 565.77
*   **20-day Moving Average:** 571.25
*   **60-day Moving Average:** 587.45

**Analysis:**

*   The current price is slightly below the previous close, indicating a small intraday decline.
*   The 5-day moving average is below the 20-day moving average, which is below the 60-day moving average. This suggests a short-term downtrend. The stock is trading below all three moving averages, reinforcing the bearish signal.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment Recommended)
*   **RSI:** 39.51 (Approaching Oversold)
*   **PPO:** 0.10
*   **Hybrid Signal:** Cash_0%_Buy 90% of cash (2 shares - Safe - MRI:0.80)
*   **Recent (20-day) Relative Divergence Change:** 0.6 (+), indicating a short-term increase in relative performance.
*   **Expected Return (%):** -202.3% (Significant underperformance vs. S&P 500 in the long term)

**Analysis:**

*   **MRI:** Suggests a moderate level of risk, supporting a medium investment allocation.
*   **RSI:** The RSI is below 40, nearing the oversold territory, which could signal a potential buying opportunity if it aligns with other indicators.
*   **PPO:** A slightly positive PPO suggests a minor uptrend in price momentum.
*   **Hybrid Signal:** Despite the negative outlook, the signal recommends buying 90% of available cash, which is an aggressive stance.
*   **Recent Divergence Change:** The short-term increase in relative performance is a positive sign, but it should be considered in the context of the overall negative divergence.
*   **Expected Return:** The extremely negative expected return suggests that, based on current trends, the model predicts substantial underperformance relative to the S&P 500 over the long term.

### 4. Recent News & Significant Events

*   **[2025-11-22]** Northrop Grumman (NOC): Assessing Value After Recent 5% Pullback in Share Price (Simply Wall St.)
*   **[2025-11-21]** How the Narrative Around Northrop Grumman Is Evolving Amid Analyst Upgrades and Sector Shifts (Simply Wall St.)
*   **[2025-11-20]** Analyst Report: Huntington Ingalls Industries, Inc. (Morningstar Research)
*   **[2025-11-20]** Janus Henderson Group to Invest in Commercial Space Station Developer Starlab Space (MT Newswires)
*   **[2025-11-20]** Starlab, Developer of Commercial Space Stations, Secures Strategic Investment from Janus Henderson (Business Wire)
*   **[2025-11-20]** Can Rocket Lab Strengthen Its Lead in Advanced Spacecraft Missions? (Zacks)

**Analysis:**

*   The news headlines suggest a mixed sentiment. The focus on a "5% pullback" and "assessing value" indicates recent price weakness.  However, the narrative around analyst upgrades and sector shifts may provide a more positive outlook. The news about space station development and investment in related companies points to broader interest and potential growth in the aerospace sector, though not directly NOC-specific.

#### 4-2) Analyst Opinions

*   **Consensus:** Buy (~2.10 on a 1-5 scale)
*   **Opinions:** 19
*   **Target Price:** Average 667.21 / High 770.00 / Low 533.00

**Analysis:**

*   Analysts, on average, have a "Buy" rating for NOC.
*   The average target price ($667.21) is significantly higher than the current price ($566.70), suggesting potential upside. However, the low target price ($533.00) is below the current price, indicating some analysts are bearish.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출        |
|------------|------|-------------|
| 2025-10-21 | 7.69 | 10.42 B$    |
| 2025-07-22 | 8.17 | 10.35 B$    |
| 2025-04-22 | 3.33 | 9.47 B$     |
| 2024-10-24 | 7.02 | 10.00 B$    |
| 2025-10-21 | 7.02 | 10.00 B$    |

**Analysis:**

*   EPS has been volatile, with a significant drop in Q2 2025 and recovery in the following quarter.
*   Revenue has been relatively stable, showing a slight increase overall. The most recent quarter shows a solid EPS and Revenue performance.

### 6. Financial Information:

**Revenue and Profitability:**

| Quarter    | Revenue     | Profit Margin |
|------------|-------------|---------------|
| 2025-09-30 | $10.42B     | 21.37%        |
| 2025-06-30 | $10.35B     | 21.35%        |
| 2025-03-31 | $9.47B      | 16.69%        |
| 2024-12-31 | $10.69B     | 18.08%        |
| 2024-09-30 | $10.00B     | 21.07%        |

**Capital and Profitability:**

| Quarter    | Equity      | ROE       |
|------------|-------------|-----------|
| 2025-09-30 | $15.99B     | 6.88%     |
| 2025-06-30 | $15.47B     | 7.59%     |
| 2025-03-31 | $14.98B     | 3.21%     |
| 2024-12-31 | $15.29B     | 8.27%     |
| 2024-09-30 | $14.75B     | 6.96%     |

**Analysis:**

*   **Revenue:** Consistent revenue generation, with recent quarters showing slight increases.
*   **Profit Margin:** Generally high profit margins, especially in the most recent quarters, indicating good operational efficiency.
*   **Equity:** Increasing equity suggests the company is retaining earnings and growing its asset base.
*   **ROE:** Fluctuating ROE, but generally solid, indicating the company is effectively using shareholder equity to generate profits.  The Q1 2025 ROE was notably lower.

### 7. Overall Summary

Based on the data provided, here's a consolidated view:

*   **Underperformance:** NOC has significantly underperformed the S&P 500 in terms of cumulative return.
*   **Bearish Momentum:** The short-term price action and moving averages suggest a downtrend.
*   **Mixed Signals:** Technical indicators provide mixed signals, with the RSI approaching oversold territory but the MRI still recommending a medium investment.
*   **Analyst Optimism:** Analysts maintain a "Buy" consensus and see potential upside, but target prices vary.
*   **Solid Financials:** The company has a solid financial base, with consistent revenue, high profit margins, and increasing equity. Recent earnings are also positive.

**Conclusion:**

NOC's current situation presents a mixed picture. While the company has a strong financial foundation and is supported by analyst optimism, its stock has significantly underperformed the market, and short-term momentum is bearish. The negative long-term expected return is also a major concern.

**Recommendations:**

*   **Caution:** Given the underperformance and negative expected return, proceed with caution.
*   **Monitor Key Levels:** Watch for a potential bounce near the oversold RSI level. Monitor the moving averages for a trend reversal.
*   **Consider Analyst Targets:**  Evaluate if the analyst target prices are realistic based on your own assessment of the company.
*   **Diversification:**  Do not over-allocate to NOC due to the higher risk profile suggested by the MDD and negative alpha.

**Disclaimer:** This analysis is based solely on the provided data and should not be considered financial advice. Consult with a qualified financial advisor before making any investment decisions.
